Zhang’s lab demonstrated that tPBM (808 nm) could not only mitigate Aβ-induced pathology (e.g., mitochondrial dysfunction, neuronal apoptosis, and tau pathology)76 but also prevent or slow the progression of AD in a rat model.77 The gene discussed is MAPT; the disease is Alzheimer disease.